BriaCell Therapeutics Corp. - BCTX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$408K
QoQ value delta ($000)
+$343K
(+527.69%)
Implied price effect (QoQ)
-36.47%
Shares
Total shares
95,802
QoQ shares delta
+86,106
(+888.06%)
Total shares held by funds (by quarter)
Market chart (BCTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 10 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| IRIDIAN ASSET MANAGEMENT LLC/CT | 272 | 65,000 | 0.11% |
| LuminArx Capital Management LP | 62 | 15,000 | 0.05% |
| UBS Group AG | 48 | 11,541 | 0.0% |
| MORGAN STANLEY | 24 | 3,501 | 0.0% |
| ROYAL BANK OF CANADA | 1 | 100 | 0.0% |
| Federation des caisses Desjardins du Quebec | 1 | 455 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 1 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 16 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 9 | 0.0% |
| Allworth Financial LP | 0 | 100 | 0.0% |
| FNY Investment Advisers, LLC | 0 | 10 | 0.0% |
| HHM Wealth Advisors, LLC | 0 | 6 | 0.0% |
| TD Waterhouse Canada Inc. | 0 | 19 | 0.0% |
| SSA SWISS ADVISORS AG | 0 | 37 | 0.0% |
| Caitong International Asset Management Co., Ltd | 0 | 7 | 0.0% |